LOAMU
ACHN

Lombard Odier Asset Management (USA)’s Achillion Pharmaceuticals ACHN Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-383,674
Closed -$2.31M – 293
2019
Q4 		$2.31M Buy
+383,674
New +$2.22M 0.21% 119

Lombard Odier Asset Management (USA)'s ACHN Position: Q1 2020 in Review

Lombard Odier Asset Management (USA) sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 383,674 shares — an estimated $2.31M sold.

Lombard Odier Asset Management (USA) first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $2.31M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Lombard Odier Asset Management (USA) reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 383,674 Achillion Pharmaceuticals shares in Q1 2020, an estimated $2.31M.
  • Lombard Odier Asset Management (USA) first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • Lombard Odier Asset Management (USA)'s Achillion Pharmaceuticals position peaked at $2.31M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2020, filed 15 May 2020.